263 related articles for article (PubMed ID: 18948497)
1. Farnesoid X receptor deficiency induces nonalcoholic steatohepatitis in low-density lipoprotein receptor-knockout mice fed a high-fat diet.
Kong B; Luyendyk JP; Tawfik O; Guo GL
J Pharmacol Exp Ther; 2009 Jan; 328(1):116-22. PubMed ID: 18948497
[TBL] [Abstract][Full Text] [Related]
2. FXR deficiency causes reduced atherosclerosis in Ldlr-/- mice.
Zhang Y; Wang X; Vales C; Lee FY; Lee H; Lusis AJ; Edwards PA
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2316-21. PubMed ID: 16825595
[TBL] [Abstract][Full Text] [Related]
3. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis.
Wouters K; van Gorp PJ; Bieghs V; Gijbels MJ; Duimel H; Lütjohann D; Kerksiek A; van Kruchten R; Maeda N; Staels B; van Bilsen M; Shiri-Sverdlov R; Hofker MH
Hepatology; 2008 Aug; 48(2):474-86. PubMed ID: 18666236
[TBL] [Abstract][Full Text] [Related]
4. Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice.
Gupte AA; Liu JZ; Ren Y; Minze LJ; Wiles JR; Collins AR; Lyon CJ; Pratico D; Finegold MJ; Wong ST; Webb P; Baxter JD; Moore DD; Hsueh WA
Hepatology; 2010 Dec; 52(6):2001-11. PubMed ID: 20938947
[TBL] [Abstract][Full Text] [Related]
5. Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.
Depner CM; Torres-Gonzalez M; Tripathy S; Milne G; Jump DB
J Nutr; 2012 Aug; 142(8):1495-503. PubMed ID: 22739374
[TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.
Depner CM; Philbrick KA; Jump DB
J Nutr; 2013 Mar; 143(3):315-23. PubMed ID: 23303872
[TBL] [Abstract][Full Text] [Related]
7. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
8. Loss of FXR protects against diet-induced obesity and accelerates liver carcinogenesis in ob/ob mice.
Zhang Y; Ge X; Heemstra LA; Chen WD; Xu J; Smith JL; Ma H; Kasim N; Edwards PA; Novak CM
Mol Endocrinol; 2012 Feb; 26(2):272-80. PubMed ID: 22261820
[TBL] [Abstract][Full Text] [Related]
9. Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice.
Subramanian S; Goodspeed L; Wang S; Kim J; Zeng L; Ioannou GN; Haigh WG; Yeh MM; Kowdley KV; O'Brien KD; Pennathur S; Chait A
J Lipid Res; 2011 Sep; 52(9):1626-35. PubMed ID: 21690266
[TBL] [Abstract][Full Text] [Related]
10. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD
Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet.
Liu X; Henkel AS; LeCuyer BE; Schipma MJ; Anderson KA; Green RM
Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G965-74. PubMed ID: 26472223
[TBL] [Abstract][Full Text] [Related]
12. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
[TBL] [Abstract][Full Text] [Related]
13. Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice.
Hanniman EA; Lambert G; McCarthy TC; Sinal CJ
J Lipid Res; 2005 Dec; 46(12):2595-604. PubMed ID: 16186601
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
[TBL] [Abstract][Full Text] [Related]
15. Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
Lytle KA; Jump DB
PLoS One; 2016; 11(1):e0146942. PubMed ID: 26761430
[TBL] [Abstract][Full Text] [Related]
16. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.
Lytle KA; Wong CP; Jump DB
PLoS One; 2017; 12(4):e0173376. PubMed ID: 28422962
[TBL] [Abstract][Full Text] [Related]
17. Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response.
Wang YD; Chen WD; Wang M; Yu D; Forman BM; Huang W
Hepatology; 2008 Nov; 48(5):1632-43. PubMed ID: 18972444
[TBL] [Abstract][Full Text] [Related]
18. Ageing Fxr deficient mice develop increased energy expenditure, improved glucose control and liver damage resembling NASH.
Bjursell M; Wedin M; Admyre T; Hermansson M; Böttcher G; Göransson M; Lindén D; Bamberg K; Oscarsson J; Bohlooly-Y M
PLoS One; 2013; 8(5):e64721. PubMed ID: 23700488
[TBL] [Abstract][Full Text] [Related]
19. Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development.
Maran RR; Thomas A; Roth M; Sheng Z; Esterly N; Pinson D; Gao X; Zhang Y; Ganapathy V; Gonzalez FJ; Guo GL
J Pharmacol Exp Ther; 2009 Feb; 328(2):469-77. PubMed ID: 18981289
[TBL] [Abstract][Full Text] [Related]
20. LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease.
Bieghs V; Van Gorp PJ; Wouters K; Hendrikx T; Gijbels MJ; van Bilsen M; Bakker J; Binder CJ; Lütjohann D; Staels B; Hofker MH; Shiri-Sverdlov R
PLoS One; 2012; 7(1):e30668. PubMed ID: 22295101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]